A multinational research team led by Columbia University and the La Jolla Institute for Immunology has identified a novel viral target that could help combat the global resurgence of measles.
New images of one of the brain’s fastest-acting proteins—the kainate receptor—are providing critical clues that may lead to targeted therapies for epilepsy and other brain disorders.
By participating in one of the world’s largest genetic studies, New Yorkers will help bring precision medicine to their communities, Columbia’s David Goldstein explains.
Among teens treated in an emergency department for drug-related symptoms, nearly 20% who used Spice, K2, or other synthetic cannabinoids experienced seizures.
Parents given a handout with flu facts at their pediatrician’s office were significantly more likely to get their kids vaccinated before the end of flu season, Columbia pediatricians have found.
A Columbia Nursing study has found that infections were 15 percent more common among patients hospitalized in units that were understaffed with nurses for two consecutive shifts.
Columbia's Sandra Soo-Jin Lee leads a national study on the inclusion of ethnic minorities in genetic studies with a goal of enhancing precision medicine.
Hematopoietic stem cells can survive extraordinary stress. Columbia scientists have learned how they escape death, which could lead to new treatments for blood cancers and diseases related to aging.
Nearly 1 in 7 brain-injured patients shows early evidence of hidden consciousness—as revealed by EEG analysis—and is more likely to recover, researchers at Columbia have found.
A new study from Columbia researchers provides robust evidence to support a simple, fixed ratio threshold for diagnosing chronic obstructive pulmonary disease (COPD).